October 5, 2023
Intellectual Asset Management
FOR IMMEDIATE RELEASE
October 5, 2023
WASHINGTON, DC—Finnegan is pleased to announce the distinction of being, according to IAM, “the law firm with the most individuals included” in the 2023 IAM Strategy 300: The World’s Leading IP Strategists list. The list recognizes individuals who are leading the way in the development and implementation of strategies that maximize the value of IP portfolios. Individuals are identified through confidential online nominations, followed by face-to-face and telephone interviews with members of the global IP community. The 10 attorneys recognized in the 2023 list are: Antje Brambrink, Frank DeCosta, Justin Hasford, Christopher Johns, Karthik Kumar, Leslie McDonell, Maeve O’Flynn, Charles Suh, Anthony Tridico, and Naoki Yoshida. These attorneys were also recognized as IAM Strategy 300 Global Leaders.
Dr. Antje Brambrink is qualified and admitted as an attorney at law in Germany. She advises and represents clients in complex patent disputes on all IP-related matters, often at the interface of antitrust and regulatory laws. Her expertise covers various fields of technology with a focus on pharmaceuticals, biotechnology, med-tech, as well as renewable energies and high-tech. As a patent litigator, Antje represents clients in infringement, preliminary injunction and inspection proceedings before German district and appeal courts as well as in nullity and compulsory license proceedings at the German Federal Patent Court and the Federal Supreme Court. In addition to her work as a litigator, Antje advises clients strategically on all issues relating to intellectual property rights (patents, utility models, supplementary protection certificates), such as contracts for the licensing and transfer of rights also in connection with international transactions or the newly established Unified Patent Court (UPC).
Frank DeCosta, Ph.D. has significant experience in patent litigation, client counseling, and providing opinions related to computers, consumer electronics, software, medical devices, and information systems. As a first chair litigator, he directed litigation teams that obtained jury and bench judgments of more than $100 million. He frequently defends clients against patent infringement charges directed to complex technologies. Frank has managed patent enforcement activities for clients in the United States, Europe, and Asia. He is involved in all phases of patent litigation in more than 50 cases, including worldwide discovery efforts, claim construction, motion practice, conducting depositions, and examining witnesses before a jury. He is also lead counsel in inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB). Most of Frank’s cases have involved technology related to his previous research, academic training, and work experience, which includes hardware and software research and development of multimedia telecommunications systems, complex signal processing systems, image processing systems, medical systems, and pattern recognition systems.
Justin Hasford focuses on complex patent litigation at the trial and appellate levels on behalf of pioneer pharmaceutical companies. He has particular experience with cases arising from Abbreviated New Drug Applications (ANDAs) under the Hatch-Waxman Act. Justin counsels clients on issues of infringement, validity, enforceability, antitrust, unfair competition, licensing, due diligence, and IP portfolio management. He has extensive experience advising clients regarding the interplay between patent and regulatory laws, including Orange Book listing of patents for drugs approved by the Food and Drug Administration (FDA). Justin has also litigated antitrust cases and business method patent cases.
Christopher Johns maintains a diverse patent practice, ranging from patent application drafting, international patent prosecution, and strategic portfolio development to district court litigation, International Trade Commission (ITC) investigations, Patent Trial and Appeal Board (PTAB) trials, and appeals to the U.S. Court of Appeals for the Federal Circuit. On the prosecution and client counseling side, Chris has experience drafting, prosecuting, and appealing patent applications related to electronics, software, telecommunications, shipping and logistics, and business methods. He provides domestic and international clients with strategic IP counseling, including portfolio management and drafting strategies. Chris has a particular focus on patent eligibility under 35 U.S.C. § 101. Chris has extensive experience with inter partes review (IPR) and covered business method (CBM) proceedings before the PTAB, district court litigations, and ITC investigations. His litigation experience extends to pre-trial investigations through trial and appeal. Chris has litigated cases relating to telecommunications, storage systems, display screens and televisions, medical devices, computer software, household goods, and other technologies.
Karthik Kumar, Ph.D., focuses on patent and trade secret litigation before federal district courts, the International Trade Commission (ITC), the Patent Trial and Appeal Board (PTAB), and the U.S. Court of Appeals for the Federal Circuit. In his strategic counseling practice, Karthik oversees global patent portfolios for technology companies focusing on emerging technologies, including 5G cellular technologies, augmented reality/virtual reality (AR/VR), artificial intelligence and machine learning, blockchain, and Internet-of-Things. Karthik serves as co-lead of Finnegan’s AR/VR industry working group and is a voting member of the Artificial Intelligence and Other Emerging Technologies Committee of the Intellectual Property Owners Association (IPO).
Leslie McDonell, managing partner of Finnegan’s Boston office, provides strategic counseling to both startups and larger companies on the procurement and protection of intellectual property in the pharmaceutical and biotechnology industries. She has extensive experience in conducting due diligence investigations and preparing companies to be the target of a due diligence, pre-litigation analyses, and offensive and defensive post-grant proceedings. Leslie has represented clients before the U.S. Patent and Trademark Office (USPTO) in patent appeals, interferences, reissues, reexaminations, and IPRs. Her U.S. litigation experience includes representation of both plaintiffs and defendants in biotechnology and pharmaceutical cases. She coordinates worldwide patent portfolio strategies; evaluates and analyzes competitors’ patent positions around the world; and advises and renders opinions on issues of patentability, inventorship, validity, claim scope, infringement, and freedom-to-operate. In addition, she has prepared and prosecuted patent applications throughout the world and has been involved in opposition and appeal proceedings in numerous countries and at the European Patent Office (EPO).
Maeve O’Flynn is a European and UK patent attorney with more than a decade of in-house experience, having worked at some of the world’s largest multinational corporations in the oil and chemical industries. She has worked for a range of clients, from startups to multinationals, covering diverse technologies such as cosmetics, sustainable chemistry, and catalysis. Maeve helps clients develop commercially relevant intellectual property strategies. This includes developing and managing global patent portfolios, provisioning advice regarding trade secrets and defensive publications, and negotiating collaboration and licensing agreements. Maeve has extensive experience preparing and prosecuting patent applications, from the initial invention harvesting sessions through to achieving allowance. She works with clients to assess and value their patent portfolios, and to develop filing strategies that support their commercial aims. She also represents clients at oral proceedings before the European Patent Office (EPO), representing both patentee and opponent.
Charles Suh is managing partner of Finnegan’s Seoul office. He practices both utility and design patent litigation before U.S. district courts and the International Trade Commission (ITC). Charles has served as lead counsel and participates in every aspect of district court and ITC litigation, and in inter partes review (IPR) proceedings at the Patent Trial and Appeal Board (PTAB). Charles’s experience includes formulating litigation and pre-litigation strategy, oral arguments, taking witness testimony at trial, taking and defending depositions, briefing, and day-to-day case management. As a fluent Korean speaker, Charles focuses on IP matters involving Korean companies and is experienced in Korea-specific litigation tasks, including managing discovery of evidentiary material written in Korean and preparation of Korean-speaking witnesses for deposition and trial. In addition, Charles has significant experience in patent portfolio management, preparing patentability, validity, and infringement opinions, and preparing and prosecuting patent applications directed to technical areas, including semiconductor fabrication/packaging, electronics, computer hardware/software, and military tactical systems.
Anthony Tridico, Ph.D., former managing partner of Finnegan’s London office and current member of the management committee, has worked in Europe for most of his career, gaining significant knowledge of the European Patent Convention (EPC) and the diversity of laws and practice among the European national systems. His knowledge of the various legal systems and how they differ from the U.S. allows Anthony to effectively counsel clients across life sciences industries with global interests in intellectual property. Anthony has over 20 years of experience representing clients with a focus on patent office trials and appeals (before the Patent Trial and Appeal Board (PTAB) and the European Patent Office (EPO)), patent prosecution management, IP due diligence and litigation. His practice includes experience in a variety of technical areas, including biologics, immunology and biotechnology, chemical and pharmaceutical sciences, polymers and adhesives, food sciences, medical devices, and diagnostics and instrumentation.
Naoki Yoshida, managing partner of Finnegan’s Tokyo office, handles a broad range of intellectual property matters, including litigation, patent portfolio management, intellectual property due diligence, client counseling, licensing and negotiations, patent prosecution, and pre-litigation strategic counseling. Naoki has significant experience in global intellectual property issues involving multinational corporations. With his fluency in Japanese and appreciation for cultural differences, he frequently counsels clients on unique intellectual property issues arising out of negotiations and disputes involving Japanese companies. Naoki has participated in proceedings in Japanese courts in connection with U.S. patent infringement litigation.
Updated on December 1, 2023 to reflect the IAM Stragegy 300 Global Leaders recognition.
Erika Arner, Managing Partner
erika.arner@finnegan.com
Anand K. Sharma, Chair
anand.sharma@finnegan.com
About Finnegan
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is one of the largest IP law firms in the world. From offices in Atlanta, Boston, London, Munich, Palo Alto, Reston, Seoul, Shanghai, Taipei, Tokyo, and Washington, DC, the firm practices European, German, UK, and U.S. IP law. In addition to services related to all aspects of patent, trademark, and copyright law, including counseling, prosecution, licensing, and litigation, Finnegan provides counseling and litigation services in advertising, privacy, and a wide spectrum of additional IP-adjacent commercial matters, including trade secrets, international trade, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com and follow us on LinkedIn.
Appeals, Issues, and Legal Strategy
Federal Circuit and Supreme Court Appeals
Diligence, Licensing, and Opinions
Unitary Patent System (UPS) and the Unified Patent Court (UPC)
ITC Section 337 Investigations
Branded Hatch-Waxman (ANDA) Litigation
Patent Invalidation Proceedings
PTAB Post-Grant Review: IPR, PGR, and CBM
Media Mention
Finnegan Shortlisted for the 2024 Asian Legal Business Japan Law Awards
April 26, 2024
Commentary
April 11, 2024
Media Mention
Women in Business Law Americas Awards 2024: Three Finnegan Attorneys Shortlisted
April 7, 2024
Press Release
Finnegan and BMW Group Successfully Demolish Non-Practicing Entity NorthStar’s Efforts
April 3, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.